Research on TSI’s new antiviral and antimicrobial technology was conducted at Sealy’s Research & Development facility in Trinity, N.C.
LEXINGTON, Ky. – Tempur Sealy International announced plans to introduce Surface-Guard Technology, an antimicrobial and antiviral technology expected to be included on select Sealy products beginning in early 2021.
The EPA-registered antimicrobial technology kills 99% of bacteria on mattress surfaces and, in testing, has also shown to be at least 99% effective in killing viruses, including human coronavirus, on textiles within five minutes, officials said.
The company is pursuing antiviral-efficacy claims approval from the U.S. Food & Drug Administration and Environmental Protection Agency.
This technology will add enhanced mattress protection across the Sealy Posturepedic and Sealy Posturepedic Plus mattress collections and will build on the antimicrobial and anti-allergen treatment (AllergenProtect) developed and first used by Tempur Sealy more than 10 years ago.
Tempur Sealy also plans to incorporate Surface-Guard Technology into the Tempur-Pedic and Stearns & Foster lines in 2021.
“Tempur Sealy is proud to announce our plans to incorporate Surface-Guard Technology antimicrobial and antiviral treatment on Sealy, Tempur-Pedic and Stearns & Foster products as soon as early next year,” said Scott Thompson, Tempur Sealy chairman and CEO. “Making Surface-Guard Technology available across our industry-leading portfolio of brands represents the latest in a long line of innovations from Tempur Sealy.
“Our planned introduction of this cutting-edge technology will help keep our mattresses clean and safe, and will be yet another reason for consumers to turn to Tempur Sealy products for their best night’s sleep.”
TSI’s Consumer Insights team found that consumers are increasingly interested in antiviral and antimicrobial mattresses in the COVID-19 climate.
The research found that, for consumers interested in purchasing a mattress within the next six months, 49% are now interested in an antiviral mattress, and 54% are now interested in an antibacterial mattress. And it found that 47% of consumers are now interested in an antimicrobial mattress.
The research also found that 63% are now interested in a removable, washable cover, a feature offered on Tempur-Pedic mattresses.
The new antiviral and antimicrobial technology marks the second major move by TSI to address the COVID-19 pandemic.
Earlier this year TSI introduced its Clean Shop Promise, designed to give consumers confidence in the mattress shopping experience. That program includes mattress shields and pillow shields and a variety of non-branded point-of-purchase materials and training assets.
Retailers participating in the program have already ordered more than 2,500 boxes of the mattress shields and more than 1,000 boxes of the pillow shields. The training materials for the Clean Shop Promise have generated than 11,000 online views, officials said.